IN2012DN01975A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01975A
IN2012DN01975A IN1975DEN2012A IN2012DN01975A IN 2012DN01975 A IN2012DN01975 A IN 2012DN01975A IN 1975DEN2012 A IN1975DEN2012 A IN 1975DEN2012A IN 2012DN01975 A IN2012DN01975 A IN 2012DN01975A
Authority
IN
India
Prior art keywords
hydrogen
pharmaceutically acceptable
alkali metal
metal ion
acceptable cation
Prior art date
Application number
Other languages
English (en)
Inventor
Bonneville George
Delahanty Greg
J Walz Andrew
Original Assignee
Eisai Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Inc filed Critical Eisai Inc
Publication of IN2012DN01975A publication Critical patent/IN2012DN01975A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1975DEN2012 2001-12-21 2002-12-20 IN2012DN01975A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34186701P 2001-12-21 2001-12-21
PCT/US2002/040748 WO2003059255A2 (fr) 2001-12-21 2002-12-20 Procede de preparation de derives de phosphonooxymethyle d'alcool et de phenol

Publications (1)

Publication Number Publication Date
IN2012DN01975A true IN2012DN01975A (fr) 2015-08-21

Family

ID=23339347

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1975DEN2012 IN2012DN01975A (fr) 2001-12-21 2002-12-20

Country Status (20)

Country Link
US (2) US7229978B2 (fr)
EP (2) EP1471920B1 (fr)
JP (2) JP4369237B2 (fr)
KR (3) KR100937162B1 (fr)
CN (2) CN101367834B (fr)
AT (1) ATE423563T1 (fr)
AU (2) AU2002360682B2 (fr)
CA (1) CA2470423C (fr)
DE (1) DE60231336D1 (fr)
ES (1) ES2322245T3 (fr)
HU (1) HU230216B1 (fr)
IL (1) IL162550A (fr)
IN (1) IN2012DN01975A (fr)
MX (1) MXPA04005892A (fr)
NZ (1) NZ533535A (fr)
PL (1) PL205940B1 (fr)
RU (1) RU2310659C2 (fr)
UA (1) UA77033C2 (fr)
WO (1) WO2003059255A2 (fr)
ZA (1) ZA200404579B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003091264A2 (fr) 2002-04-26 2003-11-06 Gilead Sciences, Inc. Inhibiteurs non nucleosidiques de la transcriptase inverse
US7300924B2 (en) 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
KR20060022647A (ko) 2003-04-25 2006-03-10 길리애드 사이언시즈, 인코포레이티드 키나아제 억제 포스포네이트 유사체
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
US7427636B2 (en) 2003-04-25 2008-09-23 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
WO2004096236A2 (fr) * 2003-04-25 2004-11-11 Gilead Sciences, Inc. Composes de phosphonate presentant une activite immunomodulatrice
WO2005002626A2 (fr) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Composes de phosphonate therapeutiques
EA014685B1 (ru) 2003-04-25 2010-12-30 Джилид Сайэнс, Инк. Фосфонатсодержащие антивирусные соединения (варианты) и фармацевтическая композиция на их основе
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
WO2005042773A1 (fr) 2003-10-24 2005-05-12 Gilead Sciences, Inc. Procedes et compositions permettant d'identifier des composes therapeutiques
WO2005044308A1 (fr) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Analogues phosphonates d'antimetabolites
WO2005044279A1 (fr) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Conjugues phosphonate / inhibiteur de purine nucleoside phosphorylase
BRPI0417988A (pt) 2003-12-22 2007-04-27 Gilead Sciences Inc análogos de fosfonato antivirais
AU2005330489B2 (en) 2004-07-27 2011-08-25 Gilead Sciences, Inc. Nucleoside phosphonate conjugates as anti HIV agents
US8658617B2 (en) 2008-07-08 2014-02-25 Gilead Sciences, Inc. Salts of HIV inhibitor compounds
KR20100032803A (ko) * 2008-09-18 2010-03-26 씨제이제일제당 (주) 아데포비어디피복실의 개선된 제조방법
CN101845057B (zh) * 2009-03-27 2013-10-23 四川大学 取代苯酚的甲缩醛磷酸盐麻醉镇静药用化合物及制备方法
US9150600B2 (en) 2009-05-07 2015-10-06 Regents Of The University Of Minnesota Triptolide prodrugs
DK2427467T3 (en) * 2009-05-07 2015-11-09 Univ Minnesota Triptolid prodrugs
JP2012140330A (ja) * 2010-12-28 2012-07-26 Tosoh Corp 水溶性リン酸エステルの精製方法
ITMI20110580A1 (it) * 2011-04-08 2012-10-09 Chemelectiva S R L Iintermedi utili per la preparazione di fospropofol e processo per la loro preparazione
UY34072A (es) 2011-05-17 2013-01-03 Novartis Ag Derivados sustituidos de indol
CN102351895A (zh) * 2011-08-08 2012-02-15 陕西合成药业有限公司 甲磷丙泊酚二钠水合物及其制备方法和用途
CN102382133B (zh) * 2011-12-02 2016-03-23 陕西合成药业股份有限公司 一种磷丙泊酚钠的制备及纯化方法
CN102516099B (zh) * 2011-12-02 2013-07-17 成都苑东药业有限公司 一种水溶性三醇胺的衍生物
CN102399236A (zh) * 2011-12-27 2012-04-04 上海立科药物化学有限公司 磷丙泊酚钠的合成方法
CN102603798A (zh) * 2012-02-14 2012-07-25 陕西合成药业有限公司 一种唑系化合物水溶性前药的制备方法
JP6254681B2 (ja) * 2013-05-09 2017-12-27 スーチュアン ハイスーク ファーマシューティカル カンパニー リミテッド フェノール誘導体及びその製造方法及び医薬的な応用
US11331271B2 (en) 2016-05-27 2022-05-17 The Johns Hopkins University Buccal, sublingual and intranasal delivery of fospropofol
SI3661937T1 (sl) 2017-08-01 2021-11-30 Gilead Sciences, Inc. Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
CN109456360B (zh) * 2018-12-17 2021-05-14 河南中医药大学 一种磷丙泊酚钠的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833827A (en) * 1955-01-17 1958-05-06 Bayer Ag Tri (3, 5-di lower alkyl-4-hydroxy phenyl)-sulfonium chlorides and method of preparing same
GB814278A (en) 1956-11-13 1959-06-03 Bataafsche Petroleum Process for the preparation of 2.4.6 trialkylated phenols
JPS56131594A (en) * 1980-03-17 1981-10-15 Mitsui Toatsu Chem Inc Preparation of alkyl phosphate
JPH04282337A (ja) * 1991-03-08 1992-10-07 Fuji Photo Film Co Ltd ２−アリールオキシ−１−クロルプロパンの製造方法
TW354293B (en) * 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US6201257B1 (en) * 1996-10-10 2001-03-13 Advanced Scientific Concepts, Inc. Semiconductor X-ray photocathodes devices
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols

Also Published As

Publication number Publication date
KR100937162B1 (ko) 2010-01-15
CN101367834B (zh) 2012-04-18
KR101016969B1 (ko) 2011-02-25
AU2002360682B2 (en) 2008-06-26
PL370489A1 (en) 2005-05-30
ATE423563T1 (de) 2009-03-15
DE60231336D1 (de) 2009-04-09
HUP0500139A2 (hu) 2005-05-30
RU2310659C2 (ru) 2007-11-20
CA2470423A1 (fr) 2003-07-24
HUP0500139A3 (en) 2005-11-28
HU230216B1 (hu) 2015-10-28
US7534776B2 (en) 2009-05-19
EP1471920A4 (fr) 2006-02-15
KR20040072659A (ko) 2004-08-18
JP4617382B2 (ja) 2011-01-26
CN1671395A (zh) 2005-09-21
WO2003059255A2 (fr) 2003-07-24
EP2058320A1 (fr) 2009-05-13
MXPA04005892A (es) 2004-11-01
ES2322245T3 (es) 2009-06-18
US20070043206A1 (en) 2007-02-22
EP2058320B1 (fr) 2012-11-21
CN100413508C (zh) 2008-08-27
UA77033C2 (uk) 2006-10-16
PL205940B1 (pl) 2010-06-30
US7229978B2 (en) 2007-06-12
NZ533535A (en) 2005-12-23
US20050124787A1 (en) 2005-06-09
JP4369237B2 (ja) 2009-11-18
WO2003059255A3 (fr) 2004-02-19
RU2004120071A (ru) 2006-01-10
IL162550A (en) 2013-08-29
JP2009149682A (ja) 2009-07-09
ZA200404579B (en) 2006-03-29
AU2008212060B2 (en) 2011-10-27
JP2005514431A (ja) 2005-05-19
AU2008212060A1 (en) 2008-10-02
KR20100101011A (ko) 2010-09-15
KR20080033551A (ko) 2008-04-16
EP1471920B1 (fr) 2009-02-25
CA2470423C (fr) 2011-03-15
AU2002360682A1 (en) 2003-07-30
EP1471920A2 (fr) 2004-11-03
CN101367834A (zh) 2009-02-18

Similar Documents

Publication Publication Date Title
IN2012DN01975A (fr)
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
BR0114316A (pt) Processo para a preparação de formulações em pó
MXPA02012795A (es) Carvedilol.
EP1040823A3 (fr) Formulations de mousse stabiles
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
DE59800935D1 (en) Immuntolerante prothrombinkomplex-präparation
GB2383041A (en) Process for the preparation of gabapentin
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
AU8889998A (en) Water soluble analogs and prodrugs of paclitaxel
CA2399709A1 (fr) Utilisation d'acide 2-methyl-thiazolidin-2,4-dicarboxylique (2-mtdc) et/ou de ses sels physiologiquement compabibles pour le traitement et/ou la prevention de cancers
AU2002365378A1 (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
CA2248794A1 (fr) Medicaments pour la prevention et le traitement d'infections virales
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
EP0900785A3 (fr) Composés apparentés à la vitamine A et procédé pour leur préparation
MXPA04004371A (es) Agente antipruritico.
IL145298A0 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
CA2353956A1 (fr) Agent therapeutique pour le traitement de la dyserection
ZA99440B (en) Condensed aromatic heterocyclic cyclopentenopyridine derivative.
WO2001070744A3 (fr) Procede de preparation de midazolame
MXPA04003738A (es) Composiciones farmaceuticas que contienen macrolidos.
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
IL133815A (en) Process for the preparation of 2-alkylthiobenzonitrile derivatives